Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children

NCT05116241 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
368
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ILiAD Biotechnologies